Standout Papers

Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following c... 2003 2026 2010 2018 12
  1. Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge (2003)
    Emilio D’Ugo, Marino Paroli et al. Vaccine

Citation Impact

Citing Papers

Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Regulation of microRNA function in animals
2018 Standout
Pathogenesis of hepatitis B virus infection
2010
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity
2023 StandoutNobel
Antimicrobial resistance in developing countries
1998
Burden of liver diseases in the world
2018 Standout
COVID-19: A promising cure for the global panic
2020 Standout
Immunogenicity and protectivity of a new liposomal hepatitis A vaccine
1997
Hepatitis C virus and microRNAs: miRed in a host of possibilities
2014
The threat of antimicrobial resistance in developing countries: causes and control strategies
2017 Standout
Molecular biology of hepatitis B virus infection
2015
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
2014 Standout
Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe
2016
Hepatitis B virus-induced oncogenesis
2007
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
2014 StandoutNobel
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Global burden of liver disease: 2023 update
2023 Standout
Fine tuning type I interferon responses
2013
Regulation of type I interferon responses
2013 Standout
The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells
2015
Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design
2015
Chronic viral hepatitis and its association with liver cancer
2017
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
2012 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
SARS-CoV-2 in wastewater: State of the knowledge and research needs
2020 Standout
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Outbreak of hepatitis A virus infection in Taiwan, June 2015 to September 2017
2019
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
EASL Clinical Practice Guidelines on hepatitis E virus infection
2018
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Gene Expression Profiling Indicates the Roles of Host Oxidative Stress, Apoptosis, Lipid Metabolism, and Intracellular Transport Genes in the Replication of Hepatitis C Virus
2010
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Hepatitis C Virus Replication-Specific Inhibition of MicroRNA Activity with Self-Cleavable Allosteric Ribozyme
2012
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel

Works of Roberto Bruni being referenced

An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones
2011
Surveillance of hepatitis A virus in urban sewages and comparison with cases notified in the course of an outbreak, Italy 2013
2014
Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C
2015
Scaffold attachment region located in a locus targeted by hepadnavirus integration in hepatocellular carcinomas
2003
Sequence and phylogenetic analysis of the VP1 gene in two cell culture-adapted HAV strains from a unique pathogenic isolate
1995
The win locus involved in activation of the distal N-myc2 gene upon WHV integration in woodchuck liver tumors harbors S/MAR elements
2004
Activation of the N-myc2 Oncogene by Woodchuck Hepatitis Virus Integration in the Linked Downstreamb3nLocus in Woodchuck Hepatocellular Carcinoma
1999
Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones
2008
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study
2014
Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks
2005
Vibrio cholerae in the Horn of Africa: Epidemiology, Plasmids, Tetracycline Resistance Gene Amplification, and Comparison Between O1 and Non-O1 Strains
1995
A computational approach identifies two regions of Hepatitis C Virus E1 protein as interacting domains involved in viral fusion process
2009
High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014
2016
Rankless by CCL
2026